Shares of Kirin Holdings Company, Limited (OTCMKTS:KNBWY - Get Free Report) hit a new 52-week low on Friday . The stock traded as low as $12.81 and last traded at $13.26, with a volume of 143886 shares trading hands. The stock had previously closed at $13.19.
Kirin Stock Performance
The company has a debt-to-equity ratio of 0.38, a current ratio of 1.42 and a quick ratio of 0.89. The business has a 50 day moving average price of $14.24 and a two-hundred day moving average price of $14.22. The stock has a market cap of $11.05 billion, a PE ratio of 14.90, a price-to-earnings-growth ratio of 1.05 and a beta of 0.19.
Kirin Company Profile
(
Get Free Report)
Kirin Holdings Company, Limited engages in food and beverages, pharmaceuticals, and health science businesses. The company's products include beer, wine, whiskey, spirits, soft drinks, dairy products, and other products. It also produces and sells pharmaceutical products, biochemical products, and other products.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kirin, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kirin wasn't on the list.
While Kirin currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.